The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 07, 2020

Filed:

Feb. 05, 2018
Applicant:

Bellicum Pharmaceuticals, Inc., Houston, TX (US);

Inventors:

Kevin Slawin, Houston, TX (US);

David Spencer, Houston, TX (US);

Aaron Edward Foster, Houston, TX (US);

Assignee:

Bellicum Pharmaceuticals, Inc., Houston, TX (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 35/17 (2015.01); A61K 35/28 (2015.01); C12N 5/00 (2006.01); A61K 38/48 (2006.01); A61K 35/545 (2015.01); A61K 38/17 (2006.01); A61K 39/00 (2006.01); A61K 48/00 (2006.01); A61K 38/16 (2006.01); A61K 35/30 (2015.01); C12N 9/64 (2006.01);
U.S. Cl.
CPC ...
A61K 38/4873 (2013.01); A61K 35/17 (2013.01); A61K 35/28 (2013.01); A61K 35/30 (2013.01); A61K 35/545 (2013.01); A61K 38/16 (2013.01); A61K 38/177 (2013.01); A61K 39/0005 (2013.01); A61K 48/005 (2013.01); C12N 5/0081 (2013.01); C12N 5/0087 (2013.01); C12N 9/6472 (2013.01); C12N 2501/48 (2013.01); C12N 2510/00 (2013.01);
Abstract

The technology relates in part to methods for inducing partial apoptosis of cells that express an inducible caspase polypeptide. The technology further relates in part to methods for inducing partial apoptosis of cells that express an inducible modified caspase polypeptide, having a modified dose response curve to the multimeric ligand inducer. The technology also relates in part to methods for cell therapy using cells that express the inducible caspase polypeptide or the inducible modified caspase polypeptide, where the proportion of caspase polypeptide-expressing cells eliminated by apoptosis is related to the administered amount of the multimeric ligand inducer.


Find Patent Forward Citations

Loading…